These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10644670)

  • 1. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol.
    Kawasaki K; Akashi S; Shimazu R; Yoshida T; Miyake K; Nishijima M
    J Biol Chem; 2000 Jan; 275(4):2251-4. PubMed ID: 10644670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol.
    Kawasaki K; Akashi S; Shimazu R; Yoshida T; Miyake K; Nishijima M
    J Endotoxin Res; 2001; 7(3):232-6. PubMed ID: 11581576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol.
    Byrd-Leifer CA; Block EF; Takeda K; Akira S; Ding A
    Eur J Immunol; 2001 Aug; 31(8):2448-57. PubMed ID: 11500829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of mouse MD-2 residues important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by alanine-scanning mutagenesis.
    Kawasaki K; Nogawa H; Nishijima M
    J Immunol; 2003 Jan; 170(1):413-20. PubMed ID: 12496426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: Gln22 of mouse MD-2 is essential for species-specific lipopolysaccharide mimetic action of taxol.
    Kawasaki K; Gomi K; Nishijima M
    J Immunol; 2001 Jan; 166(1):11-4. PubMed ID: 11123270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for lipopolysaccharide mimetic action of Taxol and flavolipin.
    Kawasaki K; Gomi K; Kawai Y; Shiozaki M; Nishijima M
    J Endotoxin Res; 2003; 9(5):301-7. PubMed ID: 14577846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavolipin, an amino acid-containing lipid unique to Flavobacterium meningosepticum.
    Gomi K; Kawasaki K; Kawai Y; Shiozaki M; Nishijima M
    J Immunol; 2002 Mar; 168(6):2939-43. PubMed ID: 11884465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.
    Shimazu R; Akashi S; Ogata H; Nagai Y; Fukudome K; Miyake K; Kimoto M
    J Exp Med; 1999 Jun; 189(11):1777-82. PubMed ID: 10359581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase.
    Rhee SH; Hwang D
    J Biol Chem; 2000 Nov; 275(44):34035-40. PubMed ID: 10952994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression.
    Perera PY; Mayadas TN; Takeuchi O; Akira S; Zaks-Zilberman M; Goyert SM; Vogel SN
    J Immunol; 2001 Jan; 166(1):574-81. PubMed ID: 11123339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B.
    Muroi M; Ohnishi T; Tanamoto K
    J Biol Chem; 2002 Nov; 277(44):42372-9. PubMed ID: 12196527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway.
    Ogawa T; Asai Y; Hashimoto M; Takeuchi O; Kurita T; Yoshikai Y; Miyake K; Akira S
    Int Immunol; 2002 Nov; 14(11):1325-32. PubMed ID: 12407023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide.
    Liu S; Gallo DJ; Green AM; Williams DL; Gong X; Shapiro RA; Gambotto AA; Humphris EL; Vodovotz Y; Billiar TR
    Infect Immun; 2002 Jul; 70(7):3433-42. PubMed ID: 12065483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.
    Akashi S; Shimazu R; Ogata H; Nagai Y; Takeda K; Kimoto M; Miyake K
    J Immunol; 2000 Apr; 164(7):3471-5. PubMed ID: 10725698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
    Hoshino K; Takeuchi O; Kawai T; Sanjo H; Ogawa T; Takeda Y; Takeda K; Akira S
    J Immunol; 1999 Apr; 162(7):3749-52. PubMed ID: 10201887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
    Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
    J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4.
    Equils O; Faure E; Thomas L; Bulut Y; Trushin S; Arditi M
    J Immunol; 2001 Feb; 166(4):2342-7. PubMed ID: 11160291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.
    Abreu MT; Vora P; Faure E; Thomas LS; Arnold ET; Arditi M
    J Immunol; 2001 Aug; 167(3):1609-16. PubMed ID: 11466383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide.
    Ohnishi T; Muroi M; Tanamoto K
    J Immunol; 2001 Sep; 167(6):3354-9. PubMed ID: 11544325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
    Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
    J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.